THE RELATIONSHIP OF PSYCHOGENIC ERECTILE DYSFUNCTION WITH CORONAVIRUS ANXIETY IN THE COVID-19 PANDEMIC PERIOD

Basit Öğe Kaydı
dc.contributor.authorOgras, Mehmet Sezai
dc.contributor.authorYildirim, Kadir
dc.date.accessioned2026-06-19T06:41:26Z
dc.date.available2026-06-19T06:41:26Z
dc.date.issued2021
dc.departmentMalatya Turgut Özal Üniversitesi
dc.description.abstractBackground/aim: Our aim is to investigate the relationship of psychogenic erectile dysfunction(pED) that develops during the new coronavirus disease(COVID-19) pandemic with coronavirus anxiety using the Coronavirus Anxiety Scale(CAS) and the International Index of Erectile Function-5(IIEF-5) questionnaire. Materials and methods: This study was conducted in Elazig Fethi sekin city hospital during January 2021 to March 2021. Medical history of male patients who were admitted to urology outpatient clinics were taken and physical examinations were performed. Morning serum fasting glucose, total testosterone and prolactine levels were measured. IIEF-5 questionnaire was filled by the patients. Two groups were formed as pED and control group. Both groups filled the CAS questionnaire and the results were compared statistically. Results: IIEF-5 scores were 15.86 +/- 7.53 and 24.26 +/- 0.82 in the pED group and the control group, respectively. The CAS scores were 7.53 +/- 2.02 and 0.40 +/- 0.62 in the pED group and in the control group, respectively. There was a significant difference between these findings. There was a significant negative correlation between IEF-5 scores and CAS scores. (p*=0.00) IIEF-5 scores were significantly lower in the pED group compared to the control group. (p*=0.00) CAS scores were significantly higher in the pED group compared to the control group. (p*=0.00) While there was a statistically significant difference between moderate pED and mild moderate pED in terms of CAS scores (p*=0.02, p*=0.00), there was no statistically significant difference between mild moderate pED and mild pED. (p=0.27). Conclusion: In addition to high contagiousness and mortality rates, COVID-19 causes economic burden and financial losses, leading to negative individual and global psychosocial impact and increased anxiety. Since anxiety is one of the etiological causes of pED, pED encountered during the COVID-19 pandemic is also associated with coronavirus anxiety. Psychiatric support for coronavirus anxiety should be added to pED treatment.
dc.identifier.endpage2381
dc.identifier.issn0393-6384
dc.identifier.issn2283-9720
dc.identifier.issue5
dc.identifier.orcid0000-0002-7417-8413
dc.identifier.startpage2377
dc.identifier.urihttps://hdl.handle.net/20.500.12899/6232
dc.identifier.volume37
dc.identifier.wosWOS:000702178700013
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherCarbone Editore
dc.relation.ispartofActa Medica Mediterranea
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20260612
dc.subjectCovid-19
dc.subjectPandemic
dc.subjectAnxiety
dc.subjectPsychogenic
dc.subjectErectile Dysfunction
dc.titleTHE RELATIONSHIP OF PSYCHOGENIC ERECTILE DYSFUNCTION WITH CORONAVIRUS ANXIETY IN THE COVID-19 PANDEMIC PERIOD
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu